Complement C7 deficiency presenting as recurrent aseptic meningitis

Annals of Allergy, Asthma and Immunology

Volumn 93, Issue 2, 2004, Pages 200-205

  Corvini, Michael ^a   Randolph, Christopher ^a   Aronin, Steven I ^a  

^a WATERBURY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C1; COMPLEMENT COMPONENT C2; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C7; COMPLEMENT COMPONENT C9;

ADULT; ANGIONEUROTIC EDEMA; ANTIBIOTIC THERAPY; APH 50 ASSAY; ARTICLE; ASEPTIC MENINGITIS; BACTERIUM DETECTION; BIOASSAY; CASE REPORT; CEREBROSPINAL FLUID EXAMINATION; CH50 ASSAY; CHEMOPROPHYLAXIS; COLLAGEN DISEASE; COMPLEMENT COMPONENT C7 DEFICIENCY; COMPLEMENT DEFICIENCY; DISEASE PREDISPOSITION; FAMILIAL DISEASE; GENETIC DISORDER; HUMAN; IMMUNOPROPHYLAXIS; INFECTION; MALE; MENINGOCOCCEMIA; NEISSERIA MENINGITIDIS; PATIENT COUNSELING; PATIENT EDUCATION; PREVALENCE; PRIORITY JOURNAL; RASH; RECURRENT ASEPTIC MENINGITIS; RECURRENT INFECTION; SCREENING;

EID: 4344591438     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61476-7     Document Type: Article

References (60)

1. Walport MJ. Complement: first of two parts. N Engl J Med. 2001;344:1058-1066.
2. Walport MJ. Complement: second of two parts. N Engl J Med. 2001;344:1140-1144.
3. Ross SC, Densen P. Complement deficiency states and infection: epidemiology, pathogenesis and consequences of neisserial and other infections in an immune deficiency. Medicine. 1984;63:243-267.
4. Wurzner R, Orren A, Lachmann P. Inherited deficiencies of the terminal components of human complement. Immunodefic Rev. 1992;3:123-147.
5. O'Hara AM, Fernie BA, Moran AP, et al. C7 deficiency in an Irish family: a deletion defect which is predominant in the Irish. Clin Exp Immunol. 1998;114:355-361.
6. Nishizaka H, Horiuchi T, Zhu ZB, et al. Molecular bases of inherited human complement component C6 deficiency in two unrelated individuals. J Immunol. 1996;156:2309-2315.
7. Nishizaka H, Horiuchi T, Zhu Z-B, Fukumori Y, Volonakis JE. Genetic bases of human complement C7 deficiency. J Immunol. 1996;157:4239-4243.
8. Fernie BA, Orren A, Sheehan G, Schlesinger M, Hobart MJ. Molecular bases of C7 deficiency: three different defects. J Immunol. 1997;159:1019-1026.
9. Fernie BA, Wurzner R, Orren A, et al. Molecular bases of combined subtotal deficiencies of C6 and C7 and their effects in combination with other deficiencies. J Immunol. 1996;157:3648-3657.
10. Coto E, Martinez-Naves E, Dominguez O, DiScipio R, Urra JM, Lopez-Larrea C. DNA polymorphisms and linkage relationship of the human complement C6, C7 and C9 genes. Immungenetics. 1991;33:184-187.
11. Fernie BA, Finlay A, Price D, et al. Complement C6 and C7 DNA polymorphisms analysed by PCR in seven ethnic groups and characteristics of the C6 Msp I RFLP. Exp Clin Immunogenet. 1996;13:92-103.
12. Fernie BA, Wurzner R, Unsworth DJ, Tuxworth RI, Hobart MJ. DNA polymorphisms of the complement C6 and C7 genes. Ann Hum Genet. 1995;59:163-181.
13. Fernie BA, Wurzner R, Orren A, Hobart MJ. A new intronic polymorphism in the C7 gene 36 bp from the common expressed C7 M/N polymorphism. Ann Hum Genet. 1996;60:179-182.
14. Fernie BA, Orren A, Schlesinger M, et al. DNA haplotypes of the complement C6 and C7 genes associated with deficiencies of the seventh component; and a new DNA polymorphism in C7 exon 13. Ann Hum Genet. 1997;61:287-298.
15. Fernie BA, Hobart MJ. Complement C7 deficiency: seven further molecular defects and their associated marker haplotypes. Hum Genet. 1998;103:513-519.
16. Hassig A. Essentielle hypokomplementamie. Pathol Microbiol (Basel). 1964;27:542-547.
17. Densen P. Complement deficiencies and meningococcal disease. Clin Exp Immunol. 1991;86(Suppl):57-62.
18. Platonov AE, Beloborodov VB, Vershinina IV. Meningococcal disease in patients with late complement component deficiency: studies in the U.S.S.R. Medicine. 1993;72:374-392.
19. Fijen CA, Kuijper EJ, Drogari-Apiranthitou M, Van Leeuwen Y, Daha MR, Dankert J. Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine. Clin Exp Immunol. 1998;114:362-369.
20. Schlesinger M, Greenberg R, Levy J, Kayhty H, Levy R. Killing of meningococci by neutrophils: effect of vaccination on patients with complement deficiency. J Infect Dis. 1994;170:449-453.
21. Andreoni J, Kayhty H, Densen P. Vaccination and the role of capsular polysaccharide antibody in prevention of recurrent meningococcal disease in late complement-deficient individuals. J Infect Dis. 1993;168:227-231.
22. Petersen BH, Lee TJ, Snyderman R, Brooks GF. Neisseria meningitidis and Neisseria gonorrhoeae bacteremia associated with C6, C7, or C8 deficiency. Ann Intern Med. 1979;90:917-920.
23. Clough JD, Clough ML, Weinstein A, et al. Familial late complement component (C6, C7) deficiency with chronic meningococcemia. Arch Intern Med. 1980;140:929-933.
24. Adams EM, Hustead S, Rubin P, Wagner R, Gewurz A, Graziano FM. Absence of the seventh component of complement in a patient with chronic meningococcemia presenting as vasculitis. Ann Intern Med. 1983;99:35-38.
25. Edwards KM, Gewurz H, Sokalski SJ, Chan L, Lint TF. Antibody and complement in the stimulation of neutrophil chemiluminescence by Neisseria meningitidis: studies in a patient with complete deficiency of C7. J Infect Dis. 1982;145:65-71.
26. Davis CA, Shurin SB, Pate K, Congeni BL. Neutrophil function in a patient with meningococcal meningitis and C7 deficiency. Am J Dis Child. 1983;137:404-406.
27. Miyake T, Ohta K, Kawamori J, Hirao T, Akagari Y, Inai S. Inherited deficiency of the seventh component of complement associated with meningococcal meningitis: lack of serum bactericidal activity against Neisseria meningitidis in a girl with C7 deficiency and HLA studies of a C7-deficient Japanese family. Microbiol Immunol. 1986;30:363-372.
28. Zimran A, Rudensky B, Kramer MR, et al. Hereditary complement deficiency in survivors of meningococcal disease: high prevalence of C7/C8 deficiency in Sephardic (Moroccan) Jews. Q J Med. 1987;63:349-358.
29. Nurnberger W, Pietsch H, Seger R, Bufon T, Wahn V. Familial deficiency of the seventh component of complement associated with recurrent meningococcal infections. Eur J Pediatr. 1989;148:758-760.
30. Schlesinger M, Nave Z, Levy Y, Slater PE, Fishelson Z. Prevalence of hereditary properdin, C7 and C8 deficiencies in patients with meningococcal infections. Clin Exp Immunol. 1990;81:423-427.
31. McBride SJ, McCluskey DR, Jackson PT. Selective C7 complement deficiency causing recurrent meningococcal infection. J Infect. 1991;22:273-276.
32. Lee TJ, Ursinger PD, Snyderman R, Yount WJ, Sparling PF. Familial deficiency of the seventh component of complement associated with recurrent bacteremic infections due to Neisseria. J Infect Dis. 1978;138:359-368.
33. Egan LJ, Orren A, Doherty J, Wurzner R, McCarthy CF. Hereditary deficiency of the seventh component of complement and recurrent meningococcal infection: investigations of an Irish family using a novel haemolytic screening assay for complement activity and C7 M/N allotyping. Epidemiol Infect. 1994;113:275-281.
34. Carpenter RR, Petersdorf RG. The clinical spectrum of bacterial meningitis. Am J Med. 1962;33:262-275.
35. Swartz MN, Dodge PR. Bacterial meningitis - a review of selected aspects, 1: general clinical features, special problems and unusual meningeal reactions mimicking bacterial meningitis (continued). N Engl J Med. 1965;272:779-787.
36. Bohr V, Rasmussen N, Hansen B, et al. 875 cases of bacterial meningitis: diagnostic procedures and the impact of preadmission antibiotic therapy: part III of a three-part series. J Infect. 1983;7:193-202.
37. Sivakmaran M, Nachman SA, Spitzer E, Aronson J. Meningococcal meningitis revisited: normocellular CSF. Clin Pediatr. 1997;351:351-355.
38. Hasbun R. The acute aseptic meningitis syndrome. Curr Infect Dis Rep. 2000;2:345-351.
39. Blockmans DE, Knockaert DC, Bobbaers HJ. Still's disease can cause neutrophilic meningitis. Neurology. 2000;54:1203-1205.
40. Bonnin AJ, Zeitz HJ, Gewurz A. Complement factor I deficiency with recurrent aseptic meningitis. Arch Intern Med. 1993;153:1380-1383.
41. Feigin RD, McCracken GH Jr, Klein JO. Diagnosis and management of meningitis. Pediatr Infect Dis J. 1992;11:785-814.
42. Ni H, Knight AI, Cartwright K, Palmer WH, McFadden J. Polymerase chain reaction for diagnosis of meningococcal meningitis. Lancet. 1992;340:1432-1434.
43. Baethgen LF, Moraes C, Weidlich L, et al. Direct-test PCR for detection of meningococcal DNA and its serogroup characterization standardization and adaptation for use in a public health laboratory. J Med Microbiol. 2003;52:793-799.
44. Richardson DC, Louie L, Louie M, Simor AE. Evaluation of a rapid PCR assay for diagnosis of meningococcal meningitis. J Clin Microbiol. 2003;41:3851-3853.
45. Saravolatz LD, Manzor O, VanderVelde N, Pawlak J, Belian B. Broad-range bacterial polymerase chain reaction for early detection of bacterial meningitis. Clin Infect Dis. 2003;36:40-45.
46. Greenlee JE. Approach to diagnosis of meningitis: cerebrospinal fluid evaluation. Infect Dis Clin North Am. 1990;4:583-599.
47. LaScolea LJ Jr, Dryja D. Quantitation of bacteria in cerebrospinal fluid and blood of children with meningitis and its diagnostic significance. J Clin Microbiol. 1984;19:187-190.
48. Feldman WE. Relation of concentrations of bacteria and bacterial antigen in cerebrospinal fluid to prognosis in patients with bacterial meningitis. N Engl J Med. 1977;296:433-435.
49. Blazer S, Berant M, Alon U. Effect of antibiotic therapy on cerebrospinal fluid. Am J Clin Pathol. 1983;80:386-387.
50. Lebel MH, McCracken GH Jr. Delayed cerebrospinal fluid sterilization and adverse outcome of bacterial meningitis in infants and children. Pediatrics. 1989;83:161-167.
51. Cartwright K, Reilly S, White D, Stuart J. Early treatment with parenteral penicillin in meningococcal disease. BMJ. 1992;305:143-147.
52. Sande MA, Korzeniowski OM, Allegro GM, Brennan RO, Zak O, Scheld M. Intermittent or continuous therapy of experimental meningitis due to Streptococcus pneumoniae in rabbits: preliminary observations on the postantibiotic effect in vivo. Rev Infect Dis. 1981;3:98-109.
53. Kanegaye JT, Soliemanzadeh P, Bradley JS. Lumbar puncture in pediatric bacterial meningitis: defining the time interval for recovery of cerebrospinal fluid pathogens after parenteral antibiotic pretreatment. Pediatrics. 2001;108:1169-1174.
54. Morgan BP, Orren A. Vaccination against meningococcus in complement-deficient individuals. Clin Exp Immunol. 1998;114:327-329.
55. Orren A. Screening for complement deficiency. Methods Mol Biol. 2000;150:139-158.
56. Potter PC, Frasch CE, van der Sande WJ, Cooper RC, Patel Y, Orren A. Prophylaxis against Neisseria meningitidis infections and antibody responses in patients with deficiency of the sixth component of complement. J Infect Dis. 1990;161:932-937.
57. Schwartz B. Chemoprophylaxis for bacterial infections: principles and application to meningococcal infections. Rev Infect Dis. 1991;13(Suppl):S170- S173.
58. Biselli R, Fattorosi A, Matricardi PM, Nisini R, Stroffolini M, Doamelio R. Dramatic reduction of meningococcal meningitis among military recruits in Italy after introduction of specific vaccination. Vaccine. 1993;11:578-581.
59. Rosenstein N, Levine O, Taylor JP, et al. Efficacy of meningococcal vaccine and barriers to vaccination. JAMA. 1998;279:435-439.
60. Pollard AJ, Levin M. Vaccines for prevention of meningococcal disease. Pediatr Infect Dis J. 2000;19:333-345.